Papers
2
Total Citations
38
H-Index
2
About
Dr. Harjeet Singh is a pioneering figure in interventional nuclear medicine, whose work centers on the fusion of advanced imaging and robotic precision for minimally invasive diagnostics. His primary research focuses on the development and validation of robotic arm-assisted biopsy techniques guided by positron emission tomography/computed tomography (PET/CT), particularly using tracers like 18F-FDG and Ga-68. Dr. Singh’s major contributions include demonstrating the high diagnostic performance of real-time robotic-arm PET/CT-guided biopsies for metabolically active abdominal and pelvic lesions, achieving a diagnostic yield that significantly reduces sampling error and patient morbidity. His landmark 2018 study on this technique has garnered 21 citations, while his subsequent 2019 work on Ga-68-guided biopsies using an automated robotic arm has earned 17 citations, collectively establishing a new standard for targeting elusive, hypermetabolic lesions. By integrating robotics with molecular imaging, Dr. Singh has enhanced the accuracy and safety of percutaneous biopsies, offering a transformative approach for diagnosing malignancies and infectious processes. His work is particularly notable for its potential to reduce repeat procedures and improve patient outcomes, positioning him as a key innovator at the intersection of robotics and nuclear medicine.
Research Focus
Key Achievements
Top Papers
- 1
- 2